Insights

Gathering insights about Immunai…

Similar companies to Immunai

Immunai Tech Stack

Immunai uses 8 technology products and services including WordPress, Salesforce, Asana, and more. Explore Immunai's tech stack below.

WordPress
Content Management System
Salesforce
Customer Relationship Management
Asana
Issue Trackers
Webflow
Page Builders
X-XSS-Protection
Security
Adobe Creative Suite
Visualisation Software
Flask
Web Frameworks
Nginx
Web Servers

Media & News

Immunai Inc. partners with AstraZeneca plc.
Immunai Inc., a New York-based biotechnology company specializing in artificial intelligence, has formed a multi-year collaboration with global pharmaceutical giant AstraZeneca.
Sep 27, 2024 | www.contractpharma.com
Immunai Inc. received financing of $215M in Series B on Jan 1st '21.
Immunai has raised over $270 million in total funding, including a $215 million Series B round in 2021.
Sep 26, 2024 | www.biopharmatrend.com
Immunai Inc. partnered with Baylor College of Medicine on May 17th '23.
Immunai recently announced results from collaboration with Baylor College of Medicine (BCM) in a review published in Nature Medicine.
Jun 17, 2023 | www.jpost.com
Immunai Inc. is developing AI platform.
Immunai is developing an AI platform that leverages big data, single cell multiomics, and machine learning to bridge the gap between casual immunology and translational disease biology.
Sep 04, 2022 | thebiotechiqpodcast.com
8vcm invested into Immunai Inc. $215M on Oct 28th '21.
Israeli-founded biotech startup Immunai announced earlier this week that it has raised a $215 million Series B round for its drug discovery platform, led by Koch Disruptive Technologies, with participation from Talos VC, 8VC, Alexandria Venture Investments, Piedmont, ICON, and previous investors.
Oct 25, 2021 | nocamels.com
Alexandria Venture Investments invested into Immunai Inc. $215M on Oct 28th '21.
Israeli-founded biotech startup Immunai announced earlier this week that it has raised a $215 million Series B round for its drug discovery platform, led by Koch Disruptive Technologies, with participation from Talos VC, 8VC, Alexandria Venture Investments, Piedmont, ICON, and previous investors.
Oct 25, 2021 | nocamels.com
Immunai Inc. hires Eli Groner as board of directors.
In conjunction with the funding, Eli Groner, Managing Director at Koch Disruptive Technologies, will be joining Immunai’s board of directors.
Oct 24, 2021 | www.finsmes.com

Immunai's Email Address Formats

Immunai uses at least 1 format(s):

Immunai Email Formats	Example	Percentage
First.Last@immunai.com	John.Doe@immunai.com	82%
First@immunai.com	John@immunai.com	16%
First.Middle@immunai.com	John.Michael@immunai.com	2%

Frequently Asked Questions

Where is Immunai's headquarters located?

Immunai's main headquarters is located at 180 Varick Street New York, NY US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Immunai's official website and social media links?

Immunai's official website is immunai.com and has social profiles on LinkedIn.

How much revenue does Immunai generate?

As of September 2024, Immunai's annual revenue reached $15M.

What is Immunai's SIC code NAICS code?

Immunai's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Immunai have currently?

As of September 2024, Immunai has approximately 162 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: N. S.Chief Of Staff: H. S.Co-Founder: D. W.. Explore Immunai's employee directory with LeadIQ.

What industry does Immunai belong to?

Immunai operates in the Biotechnology Research industry.

What technology does Immunai use?

Immunai's tech stack includes WordPressSalesforceAsanaWebflowX-XSS-ProtectionAdobe Creative SuiteFlaskNginx.

What is Immunai's email format?

Immunai's email format typically follows the pattern of . Find more Immunai email formats with LeadIQ.

How much funding has Immunai raised to date?

As of September 2024, Immunai has raised $215M in funding. The last funding round occurred on Oct 27, 2021 for $215M.

When was Immunai founded?

Immunai was founded in 2019.

Immunai

Biotechnology ResearchNew York, United States51-200 Employees

Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and  improve patient outcomes

Company Overview

Headquarters: 180 Varick Street New York, NY US
Website: immunai.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2019
Employees: 51-200

Media & News

Funding & Financials

$215M
Immunai has raised a total of $215M of funding over 3 rounds. Their latest funding round was raised on Oct 27, 2021 in the amount of $215M.
$10M$50M
Immunai's revenue is in the range of $10M$50M

Funding & Financials

$215M
Immunai has raised a total of $215M of funding over 3 rounds. Their latest funding round was raised on Oct 27, 2021 in the amount of $215M.
$10M$50M
Immunai's revenue is in the range of $10M$50M

Company Leadership

N. S.
Chief Executive Officer
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. S.
Chief Of Staff
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. W.
Co-Founder
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. H.
Ciso And It Lead
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. C.
Vp Of Finance
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

A. R.
Vice President, Platform Architecture
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. N.
Vp Strategic Alliances
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. G.
Vice President, Therapeutics Discovery
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. Z.
Vice President, Corporate Development
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. S.
Chief Of Staff
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Immunai and Millions of Other Companies
Sign up for full access to Immunai information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Immunai

Roche

nference

Accenture

Owkin

Kheiron Medical

Scipher Medicine

Brainomix

GENOOX

insitro

Cytel

Immunai Tech Stack

Media & News

Immunai Inc. partners with AstraZeneca plc.

Immunai Inc. received financing of $215M in Series B on Jan 1st '21.

Immunai Inc. partnered with Baylor College of Medicine on May 17th '23.

Immunai Inc. is developing AI platform.

8vcm invested into Immunai Inc. $215M on Oct 28th '21.

Alexandria Venture Investments invested into Immunai Inc. $215M on Oct 28th '21.

Immunai Inc. hires Eli Groner as board of directors.

Immunai's Email Address Formats

Frequently Asked Questions

Where is Immunai's headquarters located?

What is Immunai's official website and social media links?

How much revenue does Immunai generate?

What is Immunai's SIC code NAICS code?

How many employees does Immunai have currently?

What industry does Immunai belong to?

What technology does Immunai use?

What is Immunai's email format?

How much funding has Immunai raised to date?

When was Immunai founded?

Immunai

Company Overview

Media & News

Immunai Inc. partners with AstraZeneca plc.

Immunai Inc. received financing of $215M in Series B on Jan 1st '21.

Immunai Inc. partnered with Baylor College of Medicine on May 17th '23.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?